End-of-day quote
New Zealand S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
4.26
NZD
|
+2.65%
|
|
-2.74%
|
-27.80%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,097
|
5,127
|
7,609
|
4,665
|
3,598
|
2,919
|
-
|
-
|
Enterprise Value (EV)
1 |
7,421
|
6,873
|
9,876
|
7,227
|
5,901
|
5,425
|
5,449
|
5,395
|
P/E ratio
|
18.8
x
|
19.5
x
|
18.1
x
|
6.77
x
|
10.5
x
|
7.78
x
|
7.29
x
|
6.77
x
|
Yield
|
1.85%
|
2.35%
|
1.46%
|
2.39%
|
1.68%
|
-
|
-
|
1.7%
|
Capitalization / Revenue
|
15.9
x
|
12.1
x
|
16.7
x
|
9.17
x
|
6.3
x
|
4.47
x
|
4.1
x
|
3.8
x
|
EV / Revenue
|
19.4
x
|
16.2
x
|
21.7
x
|
14.2
x
|
10.3
x
|
8.31
x
|
7.66
x
|
7.02
x
|
EV / EBITDA
|
27.6
x
|
23.7
x
|
35.8
x
|
22.5
x
|
14.9
x
|
15.5
x
|
10.7
x
|
9.73
x
|
EV / FCF
|
-49.2
x
|
-26.3
x
|
-22.9
x
|
-36.7
x
|
-
|
143
x
|
-908
x
|
-48.6
x
|
FCF Yield
|
-2.03%
|
-3.81%
|
-4.36%
|
-2.73%
|
-
|
0.7%
|
-0.11%
|
-2.06%
|
Price to Book
|
2.82
x
|
2.24
x
|
2.7
x
|
1.37
x
|
0.58
x
|
0.58
x
|
0.53
x
|
0.49
x
|
Nbr of stocks (in thousands)
|
497,679
|
497,736
|
497,289
|
497,345
|
685,308
|
685,147
|
-
|
-
|
Reference price
2 |
12.25
|
10.30
|
15.30
|
9.380
|
5.250
|
4.260
|
4.260
|
4.260
|
Announcement Date
|
5/23/19
|
6/12/20
|
5/20/21
|
5/19/22
|
5/19/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
382.3
|
423.9
|
455.8
|
508.8
|
571
|
652.7
|
711.2
|
768.3
|
EBITDA
1 |
269.1
|
290
|
276.1
|
321.3
|
395.5
|
350.2
|
510
|
554.5
|
EBIT
1 |
245.9
|
261.3
|
243.8
|
285.6
|
348.9
|
325.6
|
332.1
|
373.4
|
Operating Margin
|
64.32%
|
61.65%
|
53.48%
|
56.14%
|
61.11%
|
49.89%
|
46.69%
|
48.6%
|
Earnings before Tax (EBT)
1 |
329.4
|
171.1
|
410.5
|
722.1
|
-
|
531
|
426
|
433
|
Net income
1 |
326
|
264.7
|
423.1
|
692.9
|
257.8
|
346.6
|
398.2
|
443
|
Net margin
|
85.26%
|
62.45%
|
92.82%
|
136.18%
|
45.16%
|
53.1%
|
55.99%
|
57.66%
|
EPS
2 |
0.6520
|
0.5290
|
0.8460
|
1.386
|
0.4990
|
0.5478
|
0.5844
|
0.6296
|
Free Cash Flow
1 |
-150.9
|
-261.6
|
-430.4
|
-197.1
|
-
|
38
|
-6
|
-111
|
FCF margin
|
-39.48%
|
-61.72%
|
-94.44%
|
-38.73%
|
-
|
5.82%
|
-0.84%
|
-14.45%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
10.85%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
10.97%
|
-
|
-
|
Dividend per Share
2 |
0.2270
|
0.2420
|
0.2240
|
0.2240
|
0.0880
|
-
|
-
|
0.0723
|
Announcement Date
|
5/23/19
|
6/12/20
|
5/20/21
|
5/19/22
|
5/19/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,324
|
1,746
|
2,268
|
2,562
|
2,303
|
2,506
|
2,530
|
2,476
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.921
x
|
6.022
x
|
8.213
x
|
7.973
x
|
5.823
x
|
7.157
x
|
4.961
x
|
4.466
x
|
Free Cash Flow
1 |
-151
|
-262
|
-430
|
-197
|
-
|
38
|
-6
|
-111
|
ROE (net income / shareholders' equity)
|
11%
|
10.8%
|
8.75%
|
8.14%
|
7.46%
|
6.48%
|
6.15%
|
6.38%
|
ROA (Net income/ Total Assets)
|
3.65%
|
3.38%
|
5.02%
|
6.88%
|
2.2%
|
3.9%
|
3%
|
2.9%
|
Assets
1 |
8,938
|
7,836
|
8,424
|
10,069
|
11,738
|
8,886
|
13,274
|
15,277
|
Book Value Per Share
2 |
4.340
|
4.600
|
5.660
|
6.870
|
9.030
|
7.340
|
7.960
|
8.610
|
Cash Flow per Share
2 |
0.8000
|
0.9000
|
0.8300
|
1.170
|
1.260
|
0.9500
|
1.000
|
1.080
|
Capex
1 |
552
|
711
|
844
|
783
|
1,041
|
732
|
653
|
750
|
Capex / Sales
|
144.47%
|
167.83%
|
185.08%
|
153.9%
|
182.33%
|
112.21%
|
91.79%
|
97.66%
|
Announcement Date
|
5/23/19
|
6/12/20
|
5/20/21
|
5/19/22
|
5/19/23
|
-
|
-
|
-
|
Last Close Price
4.26
NZD Average target price
7.452
NZD Spread / Average Target +74.93% Consensus |
1st Jan change
|
Capi.
|
---|
| -27.80% | 1.69B | | -14.58% | 84.68B | | +15.05% | 81.12B | | +10.49% | 29.59B | | -10.17% | 16.73B | | -1.39% | 16.36B | | -31.58% | 11.77B | | +1.82% | 11.72B | | +31.86% | 11.71B | | -0.47% | 11.66B |
Other Healthcare Facilities & Services
|